| Positive screen for depressive symptoms | Positive screen for GAD symptoms | Positive CMD Comorbiditya | |||
---|---|---|---|---|---|---|
Covariate | Univariate analysis OR (95% CI) | Multivariable analysis aOR (95% CI) | Univariate analysis OR (95% CI) | Multivariable analysis aOR (95% CI) | Univariate analysis OR (95% CI) | Multivariable analysis aOR (95% CI) |
A priori: | ||||||
 Age | 1.12** (1.02, 1.24) | 1.02 (0.91, 1.15) | 1.09* (0.97, 1.22) | 1.01 (0.88, 1.16) | 1.14** (1.01, 1.29) | 1.06 (0.92, 1.23) |
 Sex | ||||||
  Male | Ref | Ref | Ref | Ref | Ref | Ref |
  Female | 1.62** (1.04, 2.53) | 1.08 (0.63, 1.84) | 2.04*** (1.20, 3.48) | 1.41 (0.74, 2.66) | 2.07** (1.16, 3.67) | 1.45 (0.73, 2.85) |
Demographic: | ||||||
 Education level | ||||||
  Secondary | Ref | – | Ref | – | Ref | – |
  Tertiary | 1.25 (0.65, 2.41) | – | 1.41 (0.66, 3.01) | – | 1.74* (0.78, 3.89) | – |
  Primary | 1.87** (1.16, 3.01) | – | 1.87** (1.07, 3.27) | – | 2.22** (1.21, 4.07) | – |
  None | 2.03 (0.46, 8.84) | – | 2.00 (0.38, 10.47) | – | 1.17 (0.14, 10.06) | – |
 Employment | ||||||
  Student | Ref | – | Ref | – | Ref | – |
  Self-employed | 0.71 (0.29, 1.75) | – | 0.99 (0.34, 2.85) | – | 0.77 (0.24, 2.42) | – |
  Formally employed | 1.61 (0.52, 4.99) | – | 3.32* (1.03, 10.71) | – | 2.43 (0.70, 8.40) | – |
  Unemployed | 1.97*** (1.21, 3.22) | – | 2.32*** (1.28, 4.23) | – | 1.75* (0.95, 3.23) | – |
 Living arrangement | ||||||
  Family/Relative | – | – | Ref | – | Ref | – |
  Friend/non-relative | – | – | 0.58 (0.07, 4.72) | – | 0.73 (0.09, 5.93) | – |
  Alone | – | – | 2.32** (1.10, 4.88) | – | 2.56** (1.19, 5.50) | – |
Psychosocial: | ||||||
 Parental loss |  | – |  | – |  | – |
  Both parents alive | Ref | – | Ref | – | Ref | – |
  One parent alive | 1.41 (0.81, 2.44) | – | 2.03* (1.01, 4.08) | – | 1.86* (0.90, 3.86) | – |
  Both parents died | 1.86** (1.07, 3.25) | – | 2.88*** (1.44, 5.78) | – | 2.34** (1.12, 4.85) | – |
 Negative life events | ||||||
  Noneb | 0.16* (0.02, 1.22) | 0.26 (0.03, 2.02) | 1.00 | – | 1.00 | – |
  1–5 events | Ref | Ref | Ref | – | Ref | – |
  6+ events | 4.30*** (2.70, 6.84) | 2.53*** (1.50, 4.26) | 3.64*** (2.15, 6.18) | – | 3.44*** (1.96, 6.05) | – |
 Asset index | – | – | 0.81** (0.68, 0.95) | – | 0.76*** (0.63, 0.92) | – |
 Social support | 0.94*** (0.92, 0.96) | 0.96*** (0.93, 0.98) | 0.93*** (0.91, 0.96) | 0.95*** (0.92, 0.98) | 0.92*** (0.89, 0.95) | 0.94*** (0.91, 0.97) |
 Health-related quality of life | 0.95*** (0.93, 0.96) | 0.96*** (0.95, 0.98) | 0.94*** (0.93, 0.96) | 0.96*** (0.94, 0.97) | 0.95*** (0.93, 0.96) | 0.96*** (0.94, 0.98) |
 Medication adherence | ||||||
  High adherence | Ref | – | Ref | Ref | Ref | Ref |
  Medium adherence | 2.18*** (1.35, 3.52) | – | 2.01** (1.14, 3.53) | 1.58 (0.82, 3.04) | 2.08** (1.15, 3.78) | 1.76 (0.88, 3.52) |
  Low adherence | 3.83*** (1.85, 7.93) | – | 6.32*** (2.97, 13.49) | 2.97** (1.27, 6.95) | 4.77*** (2.16, 10.51) | 2.49** (1.02, 6.06) |
 Perceived HIV-stigma | 1.10*** (1.06, 1.13) | 1.04** (1.01, 1.08) | 1.13*** (1.09, 1.17) | 1.09*** (1.04, 1.14) | 1.12*** (1.07, 1.16) | 1.07*** (1.02, 1.12) |
Clinical: | ||||||
 Body Mass Index | – | – | 1.05* (0.99, 1.12) | – | – | – |
 Viral load | ||||||
  ≤ 1000 copies/mL | Ref | – | – | – | – | – |
  > 1000 copies/mL | 1.44* (0.92, 2.27) | – | – | – | – | – |
 Duration on cART | ||||||
  > 5 years | Ref | – | – | – | – | – |
  1–5 years | 1.07 (0.66, 1.75) | – | – | – | – | – |
  6-11 months | 1.54 (0.65, 3.65) | – | – | – | – | – |
  < 6 months | 2.28* (0.94, 5.53) | – | – | – | – | – |
 cART side effects | ||||||
  No | Ref | – | – | – | – | – |
  Yes | 1.75** (1.09, 2.78) | – | – | – | – | – |
n for the final model | Â | 406 | Â | 406 | Â | 406 |
Variance explained | Â | 22.3% | Â | 26.2% | Â | 25.0% |
Hosmer-Lemeshow test |  | X2 = 380.22; p-value = 0.73 |  | X2 = 437.56; p-value = 0.08 |  | X2 = 402.55; p-value = 0.43 |
cvMean AUC (95% CI) | Â | 0.78 (0.69, 0.81) | Â | 0.81 (0.77, 0.88) | Â | 0.81 (0.74, 0.86) |